High-specific-activity cellulase mutant

By protein engineering and modification of cellulase, especially the substitution of specific amino acid sequences and recombinant expression in Trichoderma reesei, the specific vitality of cellulase is improved, and the problem of insufficient specific vitality of cellulase is solved. It is suitable for The textile industry reduces production costs.

CN118956829APending Publication Date: 2024-11-15QINGDAO VLAND BIOTECH GRP CO LTD
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411164698.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2022-08-26
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The insufficient specific vitality of existing cellulases has led to limited application in industrial production, especially in the textile field, and the secretion of cellulases from bacterial sources is not suitable for industrial production.

Method used

By protein engineering of cellulase, mutants are obtained, specifically including substitution of specific sites in the amino acid sequence, such as S44N, S84D, S109V, I123L, A178S, F183V, L194I, T225P, etc., to improve their specific vitality. and recombinant expression was performed in Trichoderma reesei.

Benefits of technology

It significantly improves the specific vitality of cellulase, especially under 50°C, the specific vitality of the mutant is increased by 7.1%-59%, reducing the amount of cellulase, saving labor hours and energy, reducing production costs, and suitable for textiles. Applications in the industrial field.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to the technical field of gene engineering and protein modification, in particular to a high-specific-activity cellulase mutant and application thereof. The mutant provided by the invention comprises a substitution of an amino acid at at least one position selected from the group consisting of 44, 84, 109, 123, 178, 183, 194, 225, 234. The specific activity of the mutant under the condition of 50 DEG C is generally improved by 7.1%-38%; wherein the specific activities of the S44N single-site mutant, the I123L single-site mutant and the L194I single-site mutant are respectively improved by 26.8%, 25.7% and 38%, so that the cellulase can be widely applied to the textile field.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of genetic engineering and protein modification, and in particular to a high specific activity cellulase mutant and application thereof. Background Art

[0002] Cellulose is a polymer of glucose with β-1,4-glycosidic bonds. It is the most abundant renewable biomass on earth. However, the current utilization of cellulose is mainly reflected in direct combustion, which not only has a low utilization rate but also causes air pollution. Therefore, the effective utilization of cellulose has become a core issue of concern. Cellulase is a key factor in the effective utilization of cellulose. Cellulase is a general term for a class of complex enzymes that can degrade cellulose. The main recognized functional enzymes are endo-β-1,4-glucanase (EGs, EC 3.2.1.4), exo-β-1,4-glucanase (CBHs, EC 3.2.1.91) and β-1,4-glucosidase (BGs, EC 3.2.1.21). At present, cellulase is mainly used in the food industry, animal husbandry, pharmaceutical industry, textile industry and biomass energy industry.

[0003] Nature provides a wide range of sources for cellulase, which are widely distributed in bacteria, fungi, and actinomycetes. Studies have shown that bacteria have a weak ability to degrade cellulose because they can only secrete endoglucanase, most of which have no effect on degrading cellulose crystals, and the cellulase produced by bacteria cannot be secreted outside the cell, and the extraction and purification of the enzyme are difficult and costly, so it is not suitable for industrial production at present. Fungi are currently known microorganisms with strong ability to produce cellulase, mainly because fungi can secrete extracellular cellulase. During the growth of fungi, their hyphae can penetrate the cuticle of plants, destroy the structure of part of the lignocellulose and expose cellulose, and the secreted extracellular cellulase can directly combine with cellulose for enzymolysis, thereby improving the degradation efficiency. The ability of actinomycetes to degrade cellulose is much lower than that of fungi and bacteria, because their metabolism is very slow, the amount of cellulase produced is extremely low, the types of cellulase secreted are relatively small, and the activity against cellulase is relatively weak, so they are rarely used in industrial production.

[0004] Cellulase is essentially a protein, and its activity is affected by temperature, pH value, enzyme concentration, substrate concentration, and ionic strength. Different types of cellulase have different optimal reaction conditions. Cellulase has the advantages of mild action conditions, strong specificity, no production of other impurities, safety, and no pollution, and is a hot topic in the research of cellulose industrialization.

[0005] With the development of molecular biology technology, more and more researchers have modified enzyme molecules through protein engineering to improve their enzymatic properties. For example, Liu Danni used error-prone PCR technology to modify the nucleotide sequence of the multifunctional cellulase Nccle, thereby obtaining a multifunctional cellulase mutant Nccle-mut with high specific activity, which contains a total of 13 mutation sites. Yao Bin et al. provided a high catalytic efficiency cellulase mutant by replacing the N-terminus of a cellulase with high catalytic efficiency with the N-terminus of a cellulase with low catalytic efficiency. Under this modification condition, the mutant's specific activity was 1.8 to 6.7 times higher than that of the wild type; the catalytic efficiency was 1 to 4.7 times higher than that of the wild type; the optimal temperature and optimal pH value of the enzymatic reaction remained unchanged. Wu Bin et al. used single-point mutation technology, based on homology modeling and molecular docking methods, to optimize the molecular structure of endocellulase and improve enzyme activity by selecting key amino acids in the enzyme activity framework, and obtained a class of persistent endocellulase mutants with significantly improved enzyme activity.

[0006] At present, there have been a lot of studies on modifying the enzymatic properties of cellulase to adapt to its application in different scenarios, but specific activity is also a key indicator that limits the application of cellulase. The higher the specific activity of cellulase itself, the lower its production cost and the lower the price of the enzyme, which will be more conducive to promoting its widespread application. Summary of the invention

[0007] The purpose of the present invention is to provide a high specific activity cellulase mutant and its application. The present invention obtains a mutant protein by protein engineering of cellulase. Compared with the wild type, the specific activity of the mutant is significantly improved and can be widely used in the field of textile processing.

[0008] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0009] The present invention relates to a cellulase mutant comprising an amino acid sequence having at least 90% identity with SEQ ID NO:1 and comprising an amino acid substitution at at least one position selected from the following group: 44, 84, 109, 123, 178, 183, 194, 225, 234 compared with SEQ ID NO:1.

[0010] In some embodiments of the invention, the amino acid sequence of the mutant is at least 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or at least 99% identical to SEQ ID NO:1.

[0011] In some more specific embodiments, the amino acid sequence of the mutant is at least 99.1%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8%, or at least 99.9% identical to SEQ ID NO:1.

[0012] In some embodiments of the present invention, the mutant comprises a substitution of at least one amino acid in the following group: S44N, S84D, S109V, I123L, A178S, F183V, L194I, T225P, S234G.

[0013] In some embodiments of the present invention, the mutant comprises the following substitutions or combinations of substitutions:

[0014] S44N;

[0015] S44N / S84D;

[0016] S44N / S109V;

[0017] S44N / S111N;

[0018] S44N / I123L;

[0019] S44N / Q147R;

[0020] S44N / A178S;

[0021] S44N / L194I;

[0022] S44N / T225P;

[0023] S44N / S84D / S111N;

[0024] S44N / S109V / S111N;

[0025] S44N / S109V / I123L;

[0026] S44N / S109V / Q147R;

[0027] S44N / S111N / I123L;

[0028] S44N / S111N / L194I;

[0029] S44N / I123L / Q147R;

[0030] S44N / I123L / A178S;

[0031] S44N / I123L / L194I;

[0032] S44N / I123L / S234G;

[0033] S44N / Q147R / A178S;

[0034] S44N / Q147R / F183V;

[0035] S44N / A178S / L194I;

[0036] S44N / Q147R / T225P;

[0037] S44N / A178S / S234G;

[0038] S44N / S111N / I123L / Q147R;

[0039] S44N / S111N / I123L / L194I;

[0040] S44N / I123L / Q147R / F183V;

[0041] S44N / I123L / Q147R / L194I;

[0042] S44N / I123L / Q147R / F183V;

[0043] S44N / I123L / Q147R / L194I;

[0044] S44N / Q147R / F183V / T225P;

[0045] S44N / Q147R / F183V / S234G;

[0046] S44N / S84D / I123L / Q147R / F183V;

[0047] S44N / S84D / I123L / Q147R / L194I;

[0048] S44N / S111N / I123L / Q147R / L194I;

[0049] S44N / I123L / Q147R / A178S / L194I;

[0050] S44N / I123L / F183V / L194I / T225P;

[0051] S44N / I123L / Q147R / F183V / L194I / S234G;

[0052] S84D;

[0053] S84D / S109V;

[0054] S84D / S111N;

[0055] S84D / I123L;

[0056] S84D / Q147R;

[0057] S84D / F183V;

[0058] S84D / S109V / S111N;

[0059] S84D / S109V / I123L;

[0060] S84D / S111N / I123L;

[0061] S84D / I123L / F183V;

[0062] S84D / I123L / T225P;

[0063] S84D / I123L / S234G;

[0064] S109V;

[0065] S109V / S111N;

[0066] S109V / Q147R;

[0067] S109V / A178S;

[0068] S109V / L194I;

[0069] S109V / I123L / L194I;

[0070] S109V / I123L / T225P;

[0071] S109V / I123L / S234G;

[0072] S111N / Q147R / L194I;

[0073] S111N / I123L / Q147R / L194I;

[0074] S111N / I123L / Q147R / L194I / S234G;

[0075] I123L;

[0076] I123L / Q147R;

[0077] I123L / A178S;

[0078] I123L / L194I;

[0079] I123L / F183V;

[0080] I123L / Q147R / A178S;

[0081] I123L / Q147R / L194I;

[0082] I123L / Q147R / T225P;

[0083] I123L / A178S / L194I;

[0084] I123L / Q147R / A178S / L194I;

[0085] Q147R / A178S;

[0086] Q147R / L194I;

[0087] Q147R / A178S / L194I;

[0088] A178S;

[0089] A178S / F183V;

[0090] A178S / L194I;

[0091] A178S / T225P;

[0092] A178S / S234G;

[0093] A178S / L194I / S234G;

[0094] Q147R;

[0095] Q147R / L194I;

[0096] A178S;

[0097] A178S / L194I;

[0098] A178S / S234G;

[0099] F183V;

[0100] F183V / T225P;

[0101] F183V / S234G;

[0102] F183V / L194I / S234G;

[0103] L194I;

[0104] S111N / L194I;

[0105] L194I / S234G;

[0106] T225P;

[0107] S234G.

[0108] The present invention also relates to a DNA molecule encoding the above cellulase mutant.

[0109] The present invention also relates to a recombinant expression vector comprising the above DNA molecule.

[0110] The present invention also relates to a host cell, comprising the above recombinant expression vector.

[0111] In some embodiments of the invention, the host cell is Trichoderma reesei.

[0112] The above recombinant expression vector is transferred into the host cell of Trichoderma reesei for recombinant expression, and the obtained cellulase mutant has higher specific activity.

[0113] The invention also relates to the application of the cellulase mutant in the textile field.

[0114] The cellulase mutant provided by the present invention has higher specific activity under the condition of 50°C. Compared with the wild type, the cellulase mutants containing single-point mutations of S44N, S84D, S109V, I123L, A178S, F183V, L194I, T225P and S234G respectively have generally increased specific activity by 7.1%-38% under the condition of 50°C. Among them, the specific activity of the S44N single-point mutant, the I123L single-point mutant and the L194I single-point mutant are increased by 26.8%, 25.7% and 38% respectively, achieving unexpected technical effects.

[0115] In addition, the present invention provides two-point mutants S44N / S111N, S111N / L194I, I123L / F183V, I123L / Q147R, F183V / S234G, L194I / S234G; three-point mutants S44N / S111N / I123L, S44N / S111N / L194I, S44N / I123L / L194I, S111N / Q147R / L194I, I123L / Q147R / T225P; The four-point mutants L194I, S44N / Q147R / F183V / T225P; the five-point mutants S44N / S111N / I123L / Q147R / L194I, S111N / I123L / Q147R / D179S / L194I, S44N / I123L / F183V / L194I / T225P; and the six-point mutant S44N / I123L / Q147R / F183V / L194I / S234G generally showed a 10%-59% increase in specific activity at 50°C compared with the wild-type cellulase NT45, achieving unexpected technical results.

[0116] In summary, the cellulase mutant of the present invention is more suitable for application in the textile industry than the wild type, and can greatly reduce the amount of cellulase used, save labor time and energy, and reduce production costs. DETAILED DESCRIPTION

[0117] The present invention has used the conventional techniques and methods used in genetic engineering and molecular biology fields, for example MOLECULAR CLONING: ALABORATORY MANUAL, 3rd Ed. (Sambrook, 2001) and CURRENT PROTOCOLS IN MOLECULAR BIOLOGY (Ausubel, 2003) method of recording. These general references provide definitions and methods known to those skilled in the art. But the present invention is not limited to any concrete method, experimental scheme and reagent described.

[0118] The present invention is described in detail below in conjunction with specific implementation modes.

[0119] Example 1 Screening of cellulase mutants

[0120] In order to improve the specific activity of wild-type cellulase NT45 (amino acid sequence is SEQ ID NO: 1, encoding nucleotide sequence is SEQ ID NO: 2), the applicant screened a large number of mutations of amino acids near the active site of the enzyme using directed evolution technology.

[0121] Design PCR primers NtE-F1 and NtE-R1 as follows:

[0122] NtE-F1: GGC GAATTC ATGCGCTCCT CCACCATTC (underlined is the restriction endonuclease EcoRI recognition site);

[0123] NtE-R1: ATA GCGGCCGC TTAGGCGCACTGGTGGTAGTAGTC (the underline indicates the recognition site of restriction endonuclease NotI).

[0124] The wild-type cellulase NT45 gene (SEQ ID NO: 2) was used as a template, and PCR amplification was performed using the above primers using a GeneMorph II random mutation PCR kit (Stratagene). The PCR product was recovered from a gel, digested with EcoRI and NotI, and ligated with the pET21a vector digested with the same enzymes, transformed into Escherichia coli BL21 (DE3), spread on an LB+Amp plate, and cultured inverted at 37°C. After the transformants appeared, they were picked up one by one with a toothpick into a 96-well plate, 150 μL of LB+Amp medium containing 0.1 mM IPTG was added to each well, and the cells were cultured at 37°C and 220 rpm for about 6 h. The supernatant was discarded after centrifugation, and the cells were resuspended in a buffer solution, and the cells were repeatedly frozen and thawed to obtain an Escherichia coli cell lysate containing cellulase.

[0125] Take out 50 μL of lysate to two new 96-well plates, measure the cellulase activity and protein content at 50°C, and calculate the specific activity of different mutants.

[0126] The experimental results show that some mutations have no effect on the specific activity of cellulase at 50°C, some mutations even make it worse, and some mutations can improve the specific activity of cellulase, but their enzymatic properties have changed significantly after mutation, which do not meet the requirements. Finally, the applicant obtained mutation sites that significantly improved the specific activity at 50°C, namely: S44N, S84D, S109V, I123L, A178S, F183V, L194I, T225P, S234G.

[0127] Based on the cellulase NT45, the present invention provides cellulase mutants containing single mutation sites of S44N, S84D, S109V, I123L, A178S, F183V, L194I, T225P and S234G respectively.

[0128] The present invention also provides a cellulase mutant comprising at least 2, at least 3, at least 4, at least 5, or at least 6 mutation sites among S44N, S84D, S109V, I123L, A178S, F183V, L194I, T225P, and S234G. For example: two-point mutants such as S44N / S111N, S111N / L194I, I123L / F183V, I123L / Q147R, F183V / S234G, L194I / S234G; three-point mutants such as S44N / S111N / I123L, S44N / S111N / L194I, S44N / I123L / L194I, S111N / Q147R / L194I, I123L / Q147R / T225P; 4I, S44N / I123L / Q147R / L194I, S44N / Q147R / F183V / T225P; four-point mutants such as S44N / S111N / I123L / Q147R / L194I, S111N / I123L / Q147R / D179S / L194I, S44N / I123L / F183V / L194I / T225P; and six-point mutants such as S44N / I123L / Q147R / F183V / L194I / S234G.

[0129] Example 2 Expression of cellulase mutants in Trichoderma reesei

[0130] According to the codon preference of Trichoderma, the gene sequence of cellulase NT45 (SEQ ID NO: 2) and the gene sequence of the mutant were optimized and synthesized, and two restriction sites, KpnI and MluI, were added to the 5' and 3' ends of the synthetic sequence, respectively.

[0131] 2.1 Expression vector construction

[0132] The synthesized plasmids were digested with restriction endonucleases KpnI (Fermentas) and XbaI respectively; the plasmid pTGII was digested with restriction endonucleases KpnI (Fermentas) and XbaI at the same time; the digestion products were purified using a gel purification kit, and the two digestion products were connected using T4 DNA ligase (Fermentas); the ligation products were transformed into Trans5α Escherichia coli (Transgen), selected with ampicillin, and several clones were sequenced (Invitrogen) to ensure accuracy. After sequencing was correct, a recombinant plasmid containing a cellulase gene was obtained.

[0133] Plasmids were purified from E. coli clones with correct sequencing results using a plasmid midi-prep kit (Axygen).

[0134] 2.2 Protoplast preparation

[0135] Take a spore suspension of the host fungus Trichoderma reesei U4 with a cellulase gene defect, inoculate it on a PDA plate, and culture it at 30°C for 6 days; after the spores are abundant, cut a colony of about 1 cm×1 cm and place it in a liquid culture medium containing 120 mL YEG+U (0.5% yeast powder, 1% glucose, 0.1% uridine), and culture it at 30°C and 220 rpm for 14-16 hours; collect the mycelium by filtering with sterile gauze, and wash it once with sterile water; place the mycelium in a conical flask containing 20 mL 10 mg / mL lytic enzyme solution (Sigma L1412), and act at 30°C and 90 rpm for 1-2 hours; and observe and detect the progress of protoplast transformation under a microscope.

[0136] Add 20 mL of pre-cooled 1.2 M sorbitol (1.2 M sorbitol, 50 mM Tris-Cl, 50 mM CaCl2) to the above-mentioned conical flask, shake gently, collect the filtrate through sterile Miracloth filter cloth, centrifuge at 3000 rpm, 4°C for 10 min; discard the supernatant, add 5 mL of pre-cooled 1.2 M sorbitol solution to suspend the cells, centrifuge at 3000 rpm, 4°C for 10 min; discard the supernatant, add an appropriate amount of pre-cooled 1.2 M sorbitol to suspend and package (200 μL / tube, protoplast concentration is 10 8 / mL).

[0137] 2.3 Expression vector transformation and strain verification

[0138] The following operations were all performed on ice. 10 μg of recombinant plasmid was added to a sterile 7 mL centrifuge tube containing 200 μL of protoplast solution. Then 50 μL of 25% PEG (25% PEG, 50 mM Tris-Cl, 50 mM CaCl2) was added. The tube bottom was flicked to mix well and placed on ice for 20 min. 2 mL of 25% PEG was added. After mixing well, the mixture was placed at room temperature for 5 min. 4 mL of 1.2M sorbitol, gently mix and pour into the upper culture medium (0.1% MgSO4, 1% KH2PO4, 0.6% (NH4)2SO4, 1% glucose, 18.3% sorbitol, 0.35% agarose) melted and maintained at 55°C; gently mix and spread on the prepared lower culture medium plate (2% glucose, 0.5% (NH4)2SO4, 1.5% KH2PO4, 0.06% MgSO4, 0.06% CaCl2, 1.5% agar), and culture at 30°C for 5-7 days until transformants grow. Pick the transformants to the lower culture medium plate for rescreening, culture at 30°C for 2 days, and the strains with smoother colony edge morphology are positive transformants.

[0139] Take an appropriate amount of mycelium and place it in a 2mL centrifuge tube, add 100mg sterile quartz sand and 400μL extraction buffer (100mM Tris-HCl, 100mM EDTA, 250mM NaCl, 1% SDS); shake vigorously with a bead beater for 2min; after a 65℃ water bath for 20min, add 200μL 10M NH4AC and ice bath for 10min; centrifuge at 13000rpm for 10min; take the supernatant, add 2 times the volume of anhydrous ethanol, and place at -20℃ for 30min; centrifuge at 13000rpm for 10min, discard the supernatant; wash twice with 70% ethanol; dry, dissolve in water, and store at -20℃.

[0140] The above-extracted transformant genomic DNA was used as a template and primers M6-F and M6-R were used to perform PCR amplification of the target gene for verification.

[0141] M6-F: ATGCGCTCCT CCACCATTC;

[0142] M6-R: TTAGGCGCACTGGTGGTAGTAGTC.

[0143] The PCR amplification conditions were 94°C for 4 min; 94°C for 40 s; 58°C for 40 s, 72°C for 1 min, 30 cycles; 72°C for 7 min, 16°C; the PCR amplification products were recovered using a gel recovery kit and sequenced.

[0144] According to the above method, the applicant constructed and obtained engineered strains of Trichoderma reesei that recombinantly expressed cellulase NT45 and the above mutants.

[0145] Example 3 Fermentation Verification

[0146] The engineered strains of Trichoderma reesei obtained by the above construction were inoculated on PDA solid plates, cultured at 30°C for 6 days, and after the spores were abundant, two mycelium blocks with a diameter of 1 cm were inoculated into a 250mL Erlenmeyer flask containing 50mL fermentation medium (1.5% glucose, 1.7% lactose, 2.5% corn steep liquor, 0.44% (NH4)2SO4, 0.09% MgSO4, 2% KH2PO4, 0.04% CaCl2, 0.018% Tween-80, 0.018% trace elements), cultured at 30°C for 48 hours, and then cultured at 25°C for 48 hours. The fermentation broth was centrifuged to obtain fermentation supernatants containing cellulase NT45 and the above mutants.

[0147] 3.1 Enzyme activity assay

[0148] (1) Definition of cellulase activity

[0149] At 50°C and pH 6.0, the amount of enzyme required to degrade and release 1 μmol of reducing sugar from a 5 mg / ml sodium hydroxymethyl cellulose solution per minute is one enzyme activity unit U, where reducing sugar is expressed in equivalent amounts to glucose.

[0150] (2) Cellulase enzyme assay method

[0151] Take three test tubes and add 0.5mL CMC substrate to each, and preheat them in a 50℃ water bath with the enzyme solution to be tested for 5min. Add 0.5mL of the test solution to each of the first and second test tubes, and start the timer. React in a 50℃ water bath for 15min. After the reaction, add 1.5mL DNS reagent to each of the three test tubes, and add 0.5mL of the enzyme solution to be tested to the third test tube. Take out and shake the three test tubes, and react in a boiling water bath for 5min. Cool quickly to room temperature and adjust to 5.0mL with water. Use the test solution in the third test tube as a control to measure the absorbance of the test solutions in the first and second test tubes at a wavelength of 540nm. The absorbance should be between 0.25-0.35. The absolute value of the difference between the absorbance of the test enzyme solution reaction solution and the absorbance of the level control enzyme solution reaction solution should not exceed 0.015.

[0152] Enzyme activity X = (glucose equivalent value / 180 / 15 / 0.5) × n.

[0153] Where: X——enzyme activity unit, IU / g (mL);

[0154] 180 – Glucose converted from micrograms to micromoles;

[0155] 15——Reaction time between the test solution and the substrate;

[0156] 0.5——the amount of enzyme solution to be tested added to the reaction;

[0157] n——dilution multiple.

[0158] (3) Measurement results

[0159] The enzyme activity was tested according to the above method, and the results showed that the enzyme activity of the fermentation supernatant of the engineered Trichoderma reesei bacteria expressing the wild-type cellulase NT45 and its mutants constructed above was 80-150 U / mL at 50°C.

[0160] 3.2 Protein content determination

[0161] (1) Determination method:

[0162] The Coomassie Brilliant Blue (Bradford) binding method for determining protein content is a composite method that combines colorimetry with pigmentation. Coomassie Brilliant Blue G-250 is brownish red in acidic solution, and turns blue when combined with protein. It conforms to Beer's law within a certain protein concentration range and can be measured colorimetrically at 595nm. A large amount of absorption is achieved in 3 to 5 minutes and is stable for at least 1 hour. In the range of 10 to 1000 μg / mL, the absorbance is proportional to the protein concentration.

[0163] The enzyme solution and the Coomassie Brilliant Blue solution were mixed in a volume ratio of 1:5, allowed to stand for 10 minutes, and the protein content was determined by the Coomassie Brilliant Blue (Bradford) binding method.

[0164] (2) Protein content determination results

[0165] The cellulase protein content in the fermentation supernatant of the above-mentioned Trichoderma reesei engineering bacteria was detected according to the above method. The results showed that the protein content of the fermentation supernatant of the Trichoderma reesei engineering bacteria recombinantly expressing wild-type cellulase NT45 and its mutants was 0.04-0.1 mg / mL at 50°C.

[0166] 3.3 Calculation of specific activity

[0167] "Specific Activity" refers to the number of enzyme activity units per unit weight of protein, usually expressed as U / mg protein. Generally speaking, the higher the specific activity of an enzyme, the purer the enzyme.

[0168] The specific activity calculation formula is: specific activity (U / mg) = enzyme activity (U / mL) / protein content (mg / mL).

[0169] The specific activity of the fermentation supernatant of the engineered Trichoderma reesei expressing the recombinant cellulase NT45 and its mutants constructed in Example 3 of the present invention at 50°C is shown in Table 1.

[0170] Table 1 Specific activities of cellulase NT45 and its mutants at 50℃

[0171] Cellulase Specific activity at 50℃(U / mg) Cellulase NT45 280 S44N single point mutant 355 S84D single point mutant 314 S109V single point mutant 300 I123L single point mutant 387 A178S single point mutant 333 F183V single point mutant 304 L194I single point mutant 352 T225P single point mutant 320 S234G single point mutant 330

[0172] From the data in Table 1, it can be seen that compared with the wild-type cellulase NT45, the specific activity of the single point mutants provided by the present invention at 50°C is generally increased by 7.1%-38%, indicating that the specific activity of the single point mutants provided by the present invention at a low temperature of 50°C is significantly improved. Among them, the specific activities of the S44N single point mutant, the I123L single point mutant and the L194I single point mutant were increased by 26.8%, 25.7% and 38%, respectively, achieving unexpected technical effects.

[0173] In addition, the present invention provides two-point mutants S44N / S111N, S111N / L194I, I123L / F183V, I123L / Q147R, F183V / S234G, L194I / S234G; three-point mutants S44N / S111N / I123L, S44N / S111N / L194I, S44N / I123L / L194I, S111N / Q147R / L194I, I123L / Q147R / T225P;

[0174] The four-point mutants S44N / S111N / I123L / L194I, S44N / I123L / Q147R / L194I, and S44N / Q147R / F183V / T225P; the five-point mutants S44N / S111N / I123L / Q147R / L194I, S111N / I123L / Q147R / D179S / L194I, and S44N / I123L / F183V / L194I / T225P; and the six-point mutant S44N / I123L / Q147R / F183V / L194I / S234G generally showed a 10%-59% increase in specific activity at 50°C compared with the wild-type cellulase NT45, achieving unexpected technical results.

[0175] Example 4 Application of cellulase mutants in one-bath process for hair removal and dyeing of knitted and woven fabrics

[0176] The application temperature is 35-55℃;

[0177] The processing time is 30-150min;

[0178] pH range is 4.0-8.5;

[0179] The above process conditions are particularly suitable for dyeing in the same bath; the applicable bath ratio range is 1:5-1:30, the equipment types used are overflow dyeing machine, jigger dyeing machine, washing machine, etc., and the dosage of cellulase mutant is 240-800U / L.

[0180] The cellulase mutant provided by the invention can remove hair cleanly, causes little loss of fabric strength, and can realize dyeing and hair removal processes in one bath.

[0181] Compared with the wild-type cellulase NT45, the amount of the cellulase mutant required to achieve the same treatment effect is reduced by 31-77%, thereby significantly reducing the enzyme cost in the processing process, which is conducive to further improving and reducing production costs.

Claims

1. A cellulase mutant, characterized in that: The mutant is a cellulase having an amino acid sequence of SEQ ID NO: 1 and having any substitution or combination of substitutions selected from the following: L194I; L194I / S234G; S111N / L194I; S111N / Q147R / L194I.

2. A DNA molecule encoding the cellulase mutant according to claim 1.

3. A recombinant expression vector, characterized in that: The recombinant expression vector carries the DNA molecule according to claim 2.

4. A host cell, characterized in that The host cell carries the recombinant expression vector according to claim 3.

5. The host cell according to claim 4, characterized in that The host cell is Trichoderma reesei ( Trichoderma reesei ).

Citation Information

Patent Citations

  • Method for producing washing enzyme having protease resistance

    CN112368388A

  • Low temperature resistant cellulase mutant

    CN112795554A

  • High-specific-activity cellulase mutant and application thereof

    CN112795555A

  • Method for producing washing enzyme having protease resistance

    WO2020088393A1